This inventor holds 1 USPTO granted patent. Top assignee: Virbac Sa. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Innovations of Philippe Archimbault
Introduction
Philippe Archimbault is a notable inventor based in Monaco, MC. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on aryloxypropanolamine derivatives. His research focuses on developing compounds with potential anti-diabetic and anti-fat activities, which can be utilized in both human and veterinary medicine.
Latest Patents
Philippe Archimbault holds a patent for his invention titled "Aryloxypropanolamine derivatives, method of preparation and applications thereof." This patent describes a series of aryloxypropanolamine derivatives that comply with a specific general formula. These derivatives are designed to serve as effective agents in medical applications, particularly as additives in animal food and treatments for various health conditions. He has 1 patent related to this innovative work.
Career Highlights
Philippe Archimbault is associated with Virbac SA, a company known for its commitment to animal health. His role at Virbac has allowed him to focus on the development of new therapeutic solutions that can improve the quality of life for both humans and animals. His expertise in medicinal chemistry has positioned him as a valuable asset in the field.
Collaborations
Philippe has collaborated with notable colleagues such as Ahmed El Hadri and Arthur Donny Strosberg. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.
Conclusion
Philippe Archimbault's work exemplifies the intersection of innovation and practical application in the field of medicinal chemistry. His contributions through patents and collaborations continue to pave the way for advancements in health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile